IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Drugs and Therapy Perspectives

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

1.08

h-Index

2022-2023

 12

Rank

2022-2023

 21182

SJR

2022-2023

 0.162

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Drugs and Therapy Perspectives
Abbreviation Drugs Ther. Perspect.
Publication Type Journal
Subject Area, Categories, Scope Pharmacology (medical) (Q4)
h-index 12
Overall Rank/Ranking 21182
SCImago Journal Rank (SJR) 0.162
Impact Score 1.08
Publisher Adis International Ltd
Country United Kingdom
ISSN 11791977, 11720360
Best Quartile Q4
Coverage History 1993-2022




About Drugs and Therapy Perspectives


Drugs and Therapy Perspectives is a journal covering the technologies/fields/categories related to Pharmacology (medical) (Q4). It is published by Adis International Ltd. The overall rank of Drugs and Therapy Perspectives is 21182. According to SCImago Journal Rank (SJR), this journal is ranked 0.162. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 12. The best quartile for this journal is Q4.

The ISSN of Drugs and Therapy Perspectives journal is 11791977, 11720360. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drugs and Therapy Perspectives is cited by a total of 207 articles during the last 3 years (Preceding 2022).


Drugs and Therapy Perspectives Impact IF 2022-2023


The Impact IF 2022 of Drugs and Therapy Perspectives is 1.08, which is computed in 2023 as per its definition. Drugs and Therapy Perspectives IF is increased by a factor of 0.08 and approximate percentage change is 8% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Drugs and Therapy Perspectives Impact IF 2023 Prediction


Impact IF 2022 of Drugs and Therapy Perspectives is 1.08. If the same upward trend persists, Impact IF may rise in 2023 as well.


Impact IF Trend


Year wise Impact IF of Drugs and Therapy Perspectives. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 1.08
2021 1.00
2020 0.17
2019 0.13
2018 0.23
2017 0.15
2016 0.10
2015 0.06
2014 0.07

Drugs and Therapy Perspectives h-index


  Table Setting

Drugs and Therapy Perspectives has an h-index of 12. It means 12 articles of this journal have more than 12 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Drugs and Therapy Perspectives ISSN


The ISSN of Drugs and Therapy Perspectives is 11791977, 11720360. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Drugs and Therapy Perspectives Rank and SCImago Journal Rank (SJR)


The overall rank of Drugs and Therapy Perspectives is 21182. According to SCImago Journal Rank (SJR), this journal is ranked 0.162. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Drugs and Therapy Perspectives by Year


Year SJR
2023/2024 Coming Soon
2022 0.162
2021 0.161
2020 0.127
2019 0.115
2018 0.131
2017 0.115
2016 0.117
2015 0.112
2014 0.105

Ranking of Drugs and Therapy Perspectives by Year


Year Ranking
2023/2024 Coming Soon
2022 21182
2021 20496
2020 25729
2019 25491
2018 23362
2017 26176
2016 25747
2015 26150
2014 27366

Drugs and Therapy Perspectives Publisher


Table Setting

Drugs and Therapy Perspectives is published by Adis International Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1993-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Drugs and Therapy Perspectives is Drugs Ther. Perspect.. This abbreviation ('Drugs Ther. Perspect.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Drugs and Therapy Perspectives


If your research field is/are related to Pharmacology (medical) (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Drugs and Therapy Perspectives?

Drugs and Therapy Perspectives latest impact IF is 1.08. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 1.08 (2022) and 0.06 (2015), respectively, in the last 9 years. Moreover, its average IS is 0.33 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Drugs and Therapy Perspectives?

The Drugs and Therapy Perspectives has an SJR (SCImago Journal Rank) of 0.162, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.162 in 2022 and the lowest being 0.105 in 2014. Furthermore, the average SJR of the Drugs and Therapy Perspectives over the previous 9-year period stands at 0.33.


What's the latest h-index of the Drugs and Therapy Perspectives?

The latest h-index of the Drugs and Therapy Perspectives is 12.


Who's the publisher of the Drugs and Therapy Perspectives?

The Drugs and Therapy Perspectives is published by the Adis International Ltd, with its country of publication being the United Kingdom.


What's the current ranking of the Drugs and Therapy Perspectives?

The Drugs and Therapy Perspectives is currently ranked 21182 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 20496 in 2021 and its lowest position of 27366 in 2014.


What's the abbreviation or short name for the Drugs and Therapy Perspectives?

The standard ISO4 abbreviation for the Drugs and Therapy Perspectives is Drugs Ther. Perspect..


Is the "Drugs and Therapy Perspectives" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Drugs and Therapy Perspectives is classified as a journal that the Adis International Ltd publishes.


What's the scope or major areas of the Drugs and Therapy Perspectives?

The Drugs and Therapy Perspectives encompasses the following areas:

  • Pharmacology (medical)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Drugs and Therapy Perspectives?

The Drugs and Therapy Perspectives is assigned the following International Standard Serial Numbers (ISSN): 11791977, 11720360.


What's the best quartile of the Drugs and Therapy Perspectives?

The best quartile for the Drugs and Therapy Perspectives is Q4 (2022).


What's the coverage history of the Drugs and Therapy Perspectives?

The Drugs and Therapy Perspectives coverage history can be summarized as follows: 1993-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Field Archaeology journal 5639 Maney Publishing 43 2.38
Revue Francophone des Laboratoires (discontinued) journal 23244 Elsevier Masson s.r.l. 8 0.00
Qualitative Research journal 2108 SAGE Publications Ltd 86 3.97
Business Strategy Review journal 31512 Wiley-Blackwell Publishing Ltd 33 0.04
Air and Space Power Journal (discontinued) journal 28397 AU Press 9 0.20
Journal of Classical Sociology journal 13766 SAGE Publications Ltd 27 0.83
Marine Biology Research journal 13573 Taylor and Francis Ltd. 42 1.06
Howard Journal of Communications journal 9564 Taylor and Francis Ltd. 36 1.66
Palaeontographica Abteilung B: Palaeophytologie book series 15138 E. Schweizerbart'sche Verlagsbuchhandlung 16 2.20
International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS conference and proceedings 781 Association for Computing Machinery (ACM) 100 8.01

Check complete list




Year wise Impact Score (IS) of Drugs and Therapy Perspectives

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.08
2021 1.00
2020 0.17
2019 0.13
2018 0.23
2017 0.15
2016 0.10
2015 0.06
2014 0.07



Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Drugs
Adis International Ltd | United Kingdom

Rheumatology
Oxford University Press | United Kingdom

Acta Pharmacologica Sinica
Nature Publishing Group | United Kingdom

See All